Table 1 Patients (N = 27,710) with positive clinical sample with Gram negative-pathogen during the first 48 h from admission
From: Risk factors for detection of Pseudomonas aeruginosa in clinical samples upon hospital admission
Parameter | Total amount (%)/median (IQR) |
|---|---|
Admissions | 27,710 (100%) |
Year 2015 | 3413 (12.3%) |
Year 2016 | 4172 (15.1%) |
Year 2017 | 4170 (15%) |
Year 2018 | 5111 (18.4%) |
Year 2019 | 5542 (20%) |
Year 2020 | 5302 (19.1%) |
Length of stay | 7 (4–14) |
Age | 67 (53–77) |
Gender female | 14,422 (52%) |
Gender male | 13,288 (48%) |
Comorbidities | Â |
Charlson Comorbidity Score | 5 (2–8) |
Myocardial infarction | 558 (2%) |
Chronic heart failure | 3981 (14.4%) |
Peripheral vascular disease | 2111 (7.6%) |
Cerebrovascular disease | 2555 (9.2%) |
Dementia | 1438 (5.2%) |
Chronic pulmonary disease | 5573 (20.1%) |
Rheumatic disease | 1056 (3.8%) |
Peptic ulcer disease | 357 (1.3%) |
Mild liver disease | 1623 (5.9%) |
Diabetes without chronic complications | 4770 (17.2%) |
Diabetes with chronic complications | 1240 (4.5%) |
Chronic kidney disease | 10,333 (37.3%) |
Malignant tumor | 4911 (17.7%) |
Moderate to severe liver disease | 834 (3%) |
Metastasized solid tumor | 3032 (10.9%) |
AIDS HIV | 116 (0.4%) |
Hemiplegia | 2417 (8.7%) |
Leukaemia | 453 (1.6%) |
Lymphoma | 933 (3.4%) |
Type of Unit | Â |
Intensive care unit (ICU) | 4884 (17.6%) |
Regular ward (RW) & intermediate care unit(IMC) | 22,826 (82.4%) |
Interdisciplinary | 4751 (17.1%) |
Neurology / Neurosurgery | 1606 (5.8%) |
Visceral surgery | 2600 (9.4%) |
Internal medicine | 5257 (19%) |
Nephrology | 3226 (11.6%) |
Pediatrics | 888 (3.2%) |
Oncology | 1908 (6.9%) |
Obstetrics & Gynaecology | 1238 (4.5%) |
Urology | 1670 (6%) |
Cardiology / Visceral surgery | 2876 (10.4%) |
Cystic fibrosis | 994 (3.6%) |
Infectious Diseases | 1720 (6.2%) |
Anaesthesiology | 1481 (5.3%) |
other | 9366 (33.8%) |
Clinical Material | Â |
Blood culture | 3112 (11.2%) |
Gastrointestinal tract | 1246 (4.5%) |
CSF/otolaryngologic | 396 (1.4%) |
Respiratory Tract | 3255 (11.7%) |
Skeletal | 233 (0.8%) |
others | 5703 (20.6%) |
urine | 13,765 (49.7%) |
GN pathogen species | Â |
Citrobacter spp. | 811 (2.9%) |
Enterobacter spp. | 1769 (6.4%) |
E. coli | 14,142 (51%) |
Klebsiella spp. | 4432 (16%) |
Morganella spp. | 301 (1.1%) |
P. aeruginosa | 3764 (13.6%) |
Proteus spp. | 1919 (6.9%) |
Serratia spp. | 572 (2.1%) |
Infection & MDR detection prior to invasive detection | Â |
Previous invasive P. aeruginosa | 1071 (3.9%) |
Colonization MDR P. aeruginosa | 630 (2.3%) |
Colonization MDR E. coli | 1662 (6%) |
Colonization MDR Klebsiella spp. | 599 (2.2%) |
Colonization MDR Enterobacter spp. | 90 (0.3%) |
Colonization other MDRGN | 142 (0.5%) |